This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Denise Esposito
Denise Esposito
Washington +1 202 662 5562 Download V-card

Denise Esposito’s practice focuses on a broad range of regulatory, strategic, and policy matters affecting pharmaceutical, medical device, and food and beverage companies. She has deep experience on issues of critical importance to the life sciences industry, including the Biologics Price Competition and Innovation Act (BPCIA) and regulation of innovator biological products and biosimilars, exclusivity determinations for drugs and biological products, and the regulation and enforcement of drug promotion.

Previous Experience

  • U.S. Food and Drug Administration, Chief of Staff to the Commissioner; Deputy Chief Counsel, Drugs and Biological Products, Office of Chief Counsel; Deputy Director for Policy, Center for Drug Evaluation and Research (CDER)
  • Emergent BioSolutions Inc., Senior Vice President and General Counsel